Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Hikma Pharmaceuticals Plc ADR (HKMPY)

Hikma Pharmaceuticals Plc ADR (HKMPY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow 17.65
  • Price/Book 6.06
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
39.9300 +3.79%
on 12/26/25
42.7315 -3.01%
on 12/05/25
-0.3350 (-0.80%)
since 11/26/25
3-Month
39.9300 +3.79%
on 12/26/25
50.5600 -18.03%
on 10/07/25
-3.5250 (-7.84%)
since 09/26/25
52-Week
39.9300 +3.79%
on 12/26/25
59.2600 -30.06%
on 02/19/25
-8.5450 (-17.09%)
since 12/24/24

Most Recent Stories

More News
Hikma launches TYZAVANâ„¢ (vancomycin injection, USP) in the US

Ready-to-use sepsis therapy marks new advancement in time-critical treatment

HKMPY : 41.4450 (+0.96%)
Hikma announces Health Canada approval of KLOXXADO® (naloxone HCl) Nasal Spray 8 mg

HIK.LN : 1,533.000 (+0.46%)
EBS : 12.43 (-1.58%)
HKMPY : 41.4450 (+0.96%)
Hikma confirms that it has not signed a licensing agreement with Opiant Pharmaceuticals

/CNW/ -- Hikma Pharmaceuticals PLC (Hikma) confirms that it has not entered into any transaction with Opiant Pharmaceuticals, contrary to a PR Newswire...

HKMPY : 41.4450 (+0.96%)

Business Summary

Hikma Pharmaceuticals PLC was incorporated on September 8, 2005. The Company, together with its subsidiaries, is engaged in the development, manufacture and marketing of a broad range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid and injectable final dosage forms. Its...

See More

Key Turning Points

3rd Resistance Point 44.7275
2nd Resistance Point 43.4650
1st Resistance Point 42.4550
Last Price 41.4450
1st Support Level 40.1825
2nd Support Level 38.9200
3rd Support Level 37.9100

See More

52-Week High 59.2600
Fibonacci 61.8% 51.8759
Fibonacci 50% 49.5950
Fibonacci 38.2% 47.3141
Last Price 41.4450
52-Week Low 39.9300

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar